Alterations on the 5′ noncoding region of the BCL-6 gene are not correlated with BCL-6 protein expression in T cell non-Hodgkin Lymphomas

Laboratory Investigation

Volumn 81, Issue 12, 2001, Pages 1693-1702

  Kerl, Katrin ^a   Vonlanthen, Rene ^a   Nagy, Monika ^a   Bolzonello, Nadia J ^a   Gindre, Patricia ^a   Hurwitz, Nina ^b,c   Gudat, Fred ^b,c   Nador, Roland G ^a   Borisch, Bettina ^a  

^a Department of Pathology ^*  (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PROTEIN BCL 6; DNA BINDING PROTEIN; DNA BINDING PROTEINS; ONCOPROTEIN; PROTO ONCOGENE PROTEIN BCL 6; PROTO ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEIN BCL-6; TRANSCRIPTION FACTOR;

5' UNTRANSLATED REGION; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC ORGANIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MALIGNANT TRANSFORMATION; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; T CELL LYMPHOMA; GENETICS; MALE; METABOLISM; MUTATION;

BLOTTING, SOUTHERN; DNA-BINDING PROTEINS; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL; MALE; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS;

EID: 0034747337     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780382     Document Type: Article

References (40)

1. The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes
2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
3. BCL-6 expression during B-cell activation
4. Identification of the gene associated with the recurring chromosomal translocations t(3; 14)(q27;q32) and t(3;22)(q27;11) in B cell lymphomas
5. LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients
6. Bcl-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30 positive anaplastic large cell lymphomas
7. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease
8. BCL-6 protein is expressed in germinal-center B cells
9. Bcl-6 gene mutations in posttransplantation lymphoproliferative disorders (PT-LPDs) predict response to therapy and clinical outcome
10. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor
11. Heterologous promoters fused to Bcl-6 gene by chromosomal translocation affecting band 3q27 cause its deregulated expression during B-cell differentiation
12. A newsubtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation
13. Control of inflammation, cytokine expression, and germinal center cell formation by BCL-6
14. Cloning of a breakpoint cluster region at band 3q27 involved in human non Hodgkin's lymphoma
15. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease
16. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region
17. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells
18. Frequent mutation of the 5′ noncoding region of the BCL-6 gene in acquired immunodeficiency sydrome-related non-Hodgkin's lymphomas
19. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: Association with diffuse large-cell subtype
20. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
21. BCL-6 protein is expressed is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal thymus
22. LAZ3, a novel zinc finger encoding gene is disrupted by recurring chromosome 3q27 translocations in human lymphoma
23. Lymphocyte predominance disease: The use of cl-6 and CD57 in diagnosis and differential diagnosis
24. Rearrangements of the bcl-6 gene in diffuse large cell non-Hodgkin's lymphoma
25. Frequent somatic hypermutation of the 5′ non-coding region of the BCL-6 gene in B-cell lymphoma
26. Gene involved in the 3q27 translocation associated with B-cell lymphoma Bcl-6, encodes a Krüppel- like zinc finger protein
27. A simple salting out procedure for extracting DNA from human nucleated cells
28. BCL-6 gene product, a 92- to 98kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts
29. Analysis of LAZ3 (Bcl-6) status in B-cell non-Hodgkin's lymphoma: Results of rearrangement and gene expression studies and a mutational analysis of coding region sequences
30. Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's disease
31. Rearrangement of CCND1 (BCL1/PRAD1) 3′ untranslated region in mantlecell lymphomas and t(11q13)-associated leukemias
32. Transcriptional repression by the proto-oncogene BCL-6
33. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control
34. Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in nonHodgkin's lymphomas with BCL-6/LAZ3 rearrangement
35. The BCL-6 proto-oncogene controls germinal center formation and Th2-type inflammation
36. Chromosomal translocations cause deregulated Bcl-6 expression by promoter substitution in B-cell lymphoma
37. Alterations of a zinc fingerencoding gene, BCL-6, in diffuse large-cell lymphoma
38. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma
39. Locus-specific somatic hypermutation in germinal centre T cells